Literature DB >> 7274320

The elderly and informed consent: effects of vocabulary level and corrected feedback.

H A Taub, G E Kline, M T Baker.   

Abstract

Eighty-seven elderly adults (57-87 years of age) divided into four WAIS vocabulary subgroups (less than 40, 40-49, 50-59, greater than or equal to 60) participated in a study of comprehension and memory of an informed consent procedure. Ss in Group I read the consent form and, with the information sheet still present, answered multiple choice questions covering the main points of information. Feedback and corrected answers were then provided. Ss in Group II read the consent form but did not receive the comprehension test or feedback. All Ss were tested for memory of the information 2-3 weeks later. Results indicated that losses in performance increased with decreasing levels of vocabulary. Losses associated with low vocabulary levels appeared to be comprehension-related and did not increase in later tests of memory. The use of corrected feedback provided a significant general improvement at all vocabulary levels but did not reduce the effects due to vocabulary levels.

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1981        PMID: 7274320     DOI: 10.1080/03610738108259796

Source DB:  PubMed          Journal:  Exp Aging Res        ISSN: 0361-073X            Impact factor:   1.645


  22 in total

1.  Motivations, understanding, and voluntariness in international randomized trials.

Authors:  Nancy E Kass; Suzanne Maman; Joan Atkinson
Journal:  IRB       Date:  2005 Nov-Dec

2.  Improving health care communication for persons with mental retardation.

Authors:  D C Harper; J S Wadsworth
Journal:  Public Health Rep       Date:  1992 May-Jun       Impact factor: 2.792

3.  The use of multimedia in the informed consent process.

Authors:  H B Jimison; P P Sher; R Appleyard; Y LeVernois
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

4.  Research consent forms: continued unreadability and increasing length.

Authors:  M E LoVerde; A V Prochazka; R L Byyny
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

5.  Use of a modified informed consent process among vulnerable patients: a descriptive study.

Authors:  Rebecca L Sudore; C Seth Landefeld; Brie A Williams; Deborah E Barnes; Karla Lindquist; Dean Schillinger
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

6.  Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?

Authors:  Fay J Hlubocky; Greg A Sachs; Eric R Larson; Halla S Nimeiri; David Cella; Kristen E Wroblewski; Mark J Ratain; Jeffery M Peppercorn; Christopher K Daugherty
Journal:  J Clin Oncol       Date:  2018-07-09       Impact factor: 44.544

7.  SPIRIT advance care planning intervention in early stage dementias: An NIH stage I behavioral intervention development trial.

Authors:  Mi-Kyung Song; Sandra E Ward; Kenneth Hepburn; Sudeshna Paul; Raj C Shah; Darby J Morhardt
Journal:  Contemp Clin Trials       Date:  2018-06-02       Impact factor: 2.226

8.  Corrected Feedback: A Procedure to Enhance Recall of Informed Consent to Research among Substance Abusing Offenders.

Authors:  David S Festinger; Karen L Dugosh; Jason R Croft; Patricia L Arabia; Douglas B Marlowe
Journal:  Ethics Behav       Date:  2010-01-01

9.  Medical decision-making capacity in mild cognitive impairment: a 3-year longitudinal study.

Authors:  O C Okonkwo; H R Griffith; J N Copeland; K Belue; S Lanza; E Y Zamrini; L E Harrell; J C Brockington; D Clark; R Raman; D C Marson
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

10.  Beyond literacy and numeracy in patient provider communication: focus groups suggest roles for empowerment, provider attitude and language.

Authors:  Doug Brugge; Timothy Edgar; Kelly George; Janette Heung; M Barton Laws
Journal:  BMC Public Health       Date:  2009-09-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.